Article Sidebar

Download
PDF (Français (Canada))
Statistic
Read Counter : 3 Download : 0

Downloads

Download data is not yet available.

Main Article Content

Abstract

RÉSUMÉ
Introduction. Le cancer et ses traitements peuvent altérer la sexualité, dimension essentielle de la qualité de vie souvent négligée en pratique clinique. En Afrique subsaharienne, les données sur l'impact du cancer sur la fonction sexuelle restent limitées. Cette étude avait pour but de décrire les troubles de la sexualité et leur évolution avant et après le diagnostic de cancer chez des patients suivis à Abidjan. Méthodes. Nous avons mené une étude transversale descriptive à recueil comparatif intra-individuel, du 1er décembre 2023 au 31 janvier 2024, au CHU de Treichville. Les patients adultes, en couple et sous traitement anticancéreux, ayant donné leur consentement éclairé, ont été inclus. Les paramètres de sexualité avant le diagnostic (recueil rétrospectif) ont été comparés à ceux observés après le diagnostic. Les données ont été analysées avec SPSS 21 ; les proportions ont été comparées par le test du Chi² ou de Fisher, avec un seuil de significativité à p<0,05. Résultats. Cent patients ont été inclus (âge moyen : 48,5 ans ; 66% de femmes). Les cancers gynéco-mammaires prédominaient (46%). Après le diagnostic, une diminution significative du désir sexuel était observée (86% vs 32%, p=0,033), ainsi qu'une augmentation de l'abstinence (17% vs 62%, p<0,001). La qualité des rapports (74% vs 31%, p<0,001) et la satisfaction du partenaire (90% vs 36%, p<0,001) étaient altérées. Chez les hommes, les troubles érectiles augmentaient (11,8% vs 41,2%, p=0,033). Aucune différence significative n'était observée pour la sécheresse vaginale et la dyspareunie. Conclusion. Le cancer et ses traitements altèrent significativement la sexualité des patients, affectant le désir, la fréquence et la qualité des rapports, ainsi que la satisfaction du partenaire. L'intégration systématique de la santé sexuelle dans la prise en charge oncologique s'impose.


ABSTRACT
Introduction. Cancer and its treatments can impair sexuality, an essential dimension of quality of life that is often overlooked in clinical practice. This study aimed to describe sexual dysfunction and its evolution before and after a cancer diagnosis among patients followed in Abidjan. Method. This was a descriptive cross-sectional study with comparative data collection, conducted at Treichville University Hospital from December 1, 2023, to January 31, 2024. Adult patients in a relationship and undergoing anticancer treatment, who provided informed consent, were included. Sexuality parameters before diagnosis (retrospectively collected) were compared with those observed after diagnosis. Results. A total of 100 patients were included (mean age: 48.5 ± 12.5 years; 66% female). Gynecological and breast cancers accounted for 46% of cases. After diagnosis, a significant decrease in sexual desire was observed (86% vs 32%, p = 0.033), along with an increase in abstinence (17% vs 62%, p < 0.001). The quality of sexual intercourse (74% vs 31%, p < 0.001) and partner satisfaction (90% vs 36%, p < 0.001) were impaired. Among men, erectile dysfunction increased (11.8% vs 41.2%, p = 0.033). No significant differences were observed for vaginal dryness and dyspareunia. Conclusion. Cancer and its treatments significantly impair patients’ sexuality. Integrating sexual health into oncological care is essential.

Keywords

Sexuality, Cancer, Quality of Life, Abidjan sexualité, cancer, qualité de vie, Abidjan

Article Details

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

How to Cite
Petiori G Laurence Touré, Odo Bitti Adde, Kouassi Konan Kouamé Yvon, Emmanuelle Esther De, Ibrahima Kalil Condé, Madiou Mohamed Kassir, … Innocent Adoubi. (2026). Sexuality and Cancer in Côte d’Ivoire: Assessment of the Impact of Diagnosis and Treatments in Patients at Treichville University Hospital: Sexualité et Cancer en Côte d’Ivoire : Évaluation de l’Impact du Diagnostic et des Traitements chez les Patients au CHU de Treichville. HEALTH SCIENCES AND DISEASE, 27(9), 9–14. https://doi.org/10.67260/hsd.v27i9.7860
Download Citation
Endnote/Zotero/Mendeley (RIS)
BibTeX

References

  1. 1. Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2024;74:229–63. https://doi.org/10.3322/caac.21834.
  2. 2. International Agency for Research on Cancer. CI, Source : Globocan 2022 2024. https://gco.iarc.fr/today/data/factsheets/populations/324-guinea-fact-sheets.pdf (accessed January 17, 2025).
  3. 3. Carter J, Lacchetti C, Andersen BL, Barton DL, Bolte S, Damast S, et al. Interventions to Address Sexual Problems in People With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Adaptation of Cancer Care Ontario Guideline. J Clin Oncol Off J Am Soc Clin Oncol 2018;36:492–511. https://doi.org/10.1200/JCO.2017.75.8995.
  4. 4. Hordern A. Intimacy and sexuality after cancer: a critical review of the literature. Cancer Nurs 2008;31:E9-17. https://doi.org/10.1097/01.NCC.0000305695.12873.d5.
  5. 5. Wilson CM, McGuire DB, Rodgers BL, Elswick RK, Temkin SM. Body Image, Sexuality, and Sexual Functioning in Women with Gynecologic Cancer: An Integrative Review of the Literature and Implications for Research. Cancer Nurs 2021;44:E252–86. https://doi.org/10.1097/NCC.0000000000000818.
  6. 6. Chaudhary A, Sharma A, Gogia A, Malik PS, Batra A, kumar akash, et al. Sexual health among cancer patients on active chemotherapy: A cross-sectional study from tertiary care cancer center in India. J Clin Oncol 2023;41:e24224–e24224. https://doi.org/10.1200/JCO.2023.41.16_suppl.e24224.
  7. 7. Taylor J, Ruggiero M, Maity A, Ko K, Greenberger B, Donofree D, et al. Sexual Health Toxicity in Cancer Survivors: Is There a Gender Disparity in Physician Evaluation and Intervention? Int J Radiat Oncol Biol Phys 2020;108:S136. https://doi.org/10.1016/j.ijrobp.2020.07.872.
  8. 8. Yl T, Ba O, Mka M, Opm S, Nmp M, Pglk T, et al. Sexual Experience of Women Treated for Breast Cancer in Abidjan: Vécu de la Sexualité chez des Femmes Suivies pour un Cancer du Sein à Abidjan. Health Res Afr 2024;2. https://doi.org/10.5281/hra.v2i9.6020.
  9. 9. Konan K, Odo B, Toure Y, Prisca O, Gningayou P, Manlan N, et al. Oncosexology in côte d’Ivoire: Attitudes and Practices of Physicians Involved in the Management of Breast and Prostate Cancer. Psycho-Oncol 2024;18:359–65. https://doi.org/10.32604/po.2024.049816.
  10. 10. Addis MWG. Addressing patient sexuality issues in cancer and palliative care. Br J Nurs 2021. https://doi.org/10.12968/bjon.2021.30.10.S24.
  11. 11. Hautamäki-Lamminen K, Lipiäinen L, Beaver K, Lehto J, Kellokumpu-Lehtinen P-L. Identifying cancer patients with greater need for information about sexual issues. Eur J Oncol Nurs Off J Eur Oncol Nurs Soc 2013;17:9–15. https://doi.org/10.1016/j.ejon.2012.03.002.
  12. 12. Krouwel EM, Nicolai MPJ, van Steijn-van Tol AQMJ, Putter H, Osanto S, Pelger RCM, et al. Addressing changed sexual functioning in cancer patients: A cross-sectional survey among Dutch oncology nurses. Eur J Oncol Nurs Off J Eur Oncol Nurs Soc 2015;19:707–15. https://doi.org/10.1016/j.ejon.2015.05.005.
  13. 13. Nuytten M, Faugeras L, D’Hondt L. Cancer et sexualité. Louvain Med n.d.;137:486–91.
  14. 14. Bath C. Preserving Sexual Function in Women Treated for Cancer 2018. https://ascopost.com/issues/january-25-2018/preserving-sexual-function-in-women-treated-for-cancer/ (accessed February 15, 2025).
  15. 15. Raffo M, Di Naro A, Napolitano L, Aveta A, Cilio S, Pandolfo SD, et al. Testicular Cancer Treatments and Sexuality: A Narrative Review. Medicina (Mex) 2024;60:586. https://doi.org/10.3390/medicina60040586.
  16. 16. Nimbi FM, Magno S, Agostini L, Di Micco A, Maggiore C, De Cesaris BM, et al. Sexuality in breast cancer survivors: sexual experiences, emotions, and cognitions in a group of women under hormonal therapy. Breast Cancer Tokyo Jpn 2022;29:419–28. https://doi.org/10.1007/s12282-021-01320-2.
  17. 17. Barni S, Mondin R. Sexual dysfunction in treated breast cancer patients. Ann Oncol Off J Eur Soc Med Oncol 1997;8:149–53. https://doi.org/10.1023/a:1008298615272.
  18. 18. Smida S, Bouchahda R, Guezguez A, Regaya M, Frigui R, Kaabia O, et al. Assessment of quality of sexual life in women after breast cancer treatment: about 100 cases. Pan Afr Med J 2021;40:38. https://doi.org/10.11604/pamj.2021.40.38.29406.
  19. 19. Aupomerol DM. Santé sexuelle et vie intime n.d.
  20. 20. Venturini E. L’impact du cancer pelvien sur la sexualité et le couple: ce que nous apporte la littérature. Psycho-Oncol 2009;3:188–99. https://doi.org/10.1007/s11839-009-0147-8.
  21. 21. Fitch MI, Allard M. Perspectives des conjoints de femmes atteintes dâ€TMun cancer du sein : impact et réaction. Can Oncol Nurs J Rev Can Soins Infirm En Oncol 2007;17:72–8.
  22. 22. Hunter J. The impact of cervical cancer treatment on sexual function and intimate relationships: a crying shame. J Gynecol Oncol Nurs 2011;21:22–33.
  23. 23. Vermeer WM, Bakker RM, Kenter GG, Stiggelbout AM, Ter Kuile MM. Cervical cancer survivors’ and partners’ experiences with sexual dysfunction and psychosexual support. Support Care Cancer 2016;24:1679–87. https://doi.org/10.1007/s00520-015-2925-0.
  24. 24. Juraskova I, Butow P, Robertson R, Sharpe L, McLeod C, Hacker N. Post-treatment sexual adjustment following cervical and endometrial cancer: a qualitative insight. Psychooncology 2003;12:267–79. https://doi.org/10.1002/pon.639.

Most read articles by the same author(s)